RU2657573C2 - Применение долгодействующих пептидов glp-1 - Google Patents

Применение долгодействующих пептидов glp-1 Download PDF

Info

Publication number
RU2657573C2
RU2657573C2 RU2015101826A RU2015101826A RU2657573C2 RU 2657573 C2 RU2657573 C2 RU 2657573C2 RU 2015101826 A RU2015101826 A RU 2015101826A RU 2015101826 A RU2015101826 A RU 2015101826A RU 2657573 C2 RU2657573 C2 RU 2657573C2
Authority
RU
Russia
Prior art keywords
glp
agonist
specified
paragraphs
use according
Prior art date
Application number
RU2015101826A
Other languages
English (en)
Russian (ru)
Other versions
RU2015101826A (ru
Inventor
Кристин Бьёрн ЕНСЕН
Мадс Фредерик РАСМУССЕН
Милан ЗДРАВКОВИЧ
Петер КРИСТЕНСЕН
Original Assignee
Ново Нордиск А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ново Нордиск А/С filed Critical Ново Нордиск А/С
Publication of RU2015101826A publication Critical patent/RU2015101826A/ru
Application granted granted Critical
Publication of RU2657573C2 publication Critical patent/RU2657573C2/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Child & Adolescent Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
RU2015101826A 2012-07-01 2013-06-21 Применение долгодействующих пептидов glp-1 RU2657573C2 (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP12174535.0 2012-07-01
EP12174535 2012-07-01
US201261694837P 2012-08-30 2012-08-30
US61/694,837 2012-08-30
US201261708162P 2012-10-01 2012-10-01
US61/708,162 2012-10-01
EP12186781 2012-10-01
EP12186781.6 2012-10-01
PCT/EP2013/063004 WO2014005858A1 (en) 2012-07-01 2013-06-21 Use of long-acting glp-1 peptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2018117557A Division RU2018117557A (ru) 2012-07-01 2013-06-21 Применение долгодействующих пептидов glp-1

Publications (2)

Publication Number Publication Date
RU2015101826A RU2015101826A (ru) 2016-08-20
RU2657573C2 true RU2657573C2 (ru) 2018-06-14

Family

ID=65858459

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2018117557A RU2018117557A (ru) 2012-07-01 2013-06-21 Применение долгодействующих пептидов glp-1
RU2015101826A RU2657573C2 (ru) 2012-07-01 2013-06-21 Применение долгодействующих пептидов glp-1

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2018117557A RU2018117557A (ru) 2012-07-01 2013-06-21 Применение долгодействующих пептидов glp-1

Country Status (17)

Country Link
US (2) US9764003B2 (enExample)
EP (3) EP4406593A3 (enExample)
JP (1) JP6059802B2 (enExample)
AU (3) AU2013286177B2 (enExample)
BR (1) BR112014032938A2 (enExample)
CA (1) CA2877056A1 (enExample)
DK (1) DK2866825T3 (enExample)
ES (2) ES2796839T3 (enExample)
HR (2) HRP20251088T1 (enExample)
HU (1) HUE049152T2 (enExample)
MX (3) MX376058B (enExample)
PL (2) PL3689365T3 (enExample)
PT (1) PT2866825T (enExample)
RS (2) RS60432B1 (enExample)
RU (2) RU2018117557A (enExample)
SI (1) SI2866825T1 (enExample)
WO (1) WO2014005858A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20180425T1 (hr) 2010-12-16 2018-04-20 Novo Nordisk A/S Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
BR112013026195A2 (pt) 2011-04-12 2016-11-29 Novo Nordisk As derivados de glp-1 duplamente acilados
SMT201800491T1 (it) 2012-03-22 2018-11-09 Novo Nordisk As Composizioni di peptidi glp-1 e relativa preparazione
JP6517690B2 (ja) 2012-06-20 2019-05-22 ノヴォ ノルディスク アー／エス ペプチド及び送達剤を含む錠剤製剤
JP6059802B2 (ja) 2012-07-01 2017-01-11 ノヴォ ノルディスク アー／エス 長時間作用型ｇｌｐ−１ペプチドの使用
ES2688462T3 (es) 2013-05-02 2018-11-02 Novo Nordisk A/S Dosificación oral de compuestos de GLP-1
CN107074109B (zh) * 2014-10-16 2019-10-25 洋马株式会社 拖拉机
GB201621987D0 (en) * 2016-12-22 2017-02-08 Archer Virgil L See Archer Sheri A Arecor Ltd Novel composition
DE102017106216A1 (de) * 2017-03-22 2018-09-27 Amw Gmbh Extrudierte Depotform zur anhaltenden Wirkstofffreisetzung
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
IL322968A (en) 2017-10-12 2025-10-01 Novo Nordisk As Semaglutide in medical treatment
GB201720187D0 (en) * 2017-12-04 2018-01-17 Imperial Innovations Ltd Novel Compounds
EP3746111B1 (en) 2018-02-02 2023-07-19 Novo Nordisk A/S Solid compositions comprising a glp-1 agonist, a salt of n-(8-(2-hydroxybenzoyl)amino)caprylic acid and a lubricant
TWI705820B (zh) 2018-06-22 2020-10-01 美商美國禮來大藥廠 Gip/glp1促效劑組合物
US20210162013A1 (en) * 2018-08-03 2021-06-03 Brown University Compositions and methods for improving the bioavailability of glp1 and analogues thereof
JP2022521551A (ja) * 2019-02-26 2022-04-08 ツイスト バイオサイエンス コーポレーション Ｇｌｐ１受容体の変異体核酸ライブラリ
EP4414031A3 (en) * 2019-11-06 2025-02-05 Novo Nordisk A/S Glp-1 receptor agonists in dementia
WO2021136303A1 (zh) * 2019-12-30 2021-07-08 甘李药业股份有限公司 长效glp-1化合物
MX2022009844A (es) * 2020-02-18 2022-09-05 Novo Nordisk As Composiciones y usos del peptido similar al glucagon-1 (glp-1).
CN112768087A (zh) * 2020-12-23 2021-05-07 吉林大学 利用孟德尔随机化方法验证索马鲁肽口服制剂预防二型糖尿病的用途
EP4359074A4 (en) * 2021-06-24 2025-06-04 Gila Therapeutics, Inc. METHODS AND KITS FOR INDUCTING SATOURAGE AND TREATMENT OF METABOLIC DISEASES
US11865213B2 (en) * 2021-07-05 2024-01-09 Mapi Pharma Ltd. Semaglutide depot systems and use thereof
WO2023049518A1 (en) 2021-09-27 2023-03-30 Terns Pharmaceuticals, Inc. Benzimidazole carboxylic acids as glp-1r agonists
WO2023076237A1 (en) 2021-10-25 2023-05-04 Terns Pharmaceuticals, Inc. Compounds as glp-1r agonists
JP2024544920A (ja) 2021-11-10 2024-12-05 アイ２オー セラピューティクス，インク． イオン液体組成物
CN115850438B (zh) * 2021-12-28 2023-05-12 北京惠之衡生物科技有限公司 一种长效glp-1衍生物
PE20250741A1 (es) 2022-02-23 2025-03-13 Terns Pharmaceuticals Inc Compuestos como agonistas de glp-1r
WO2023225370A1 (en) * 2022-05-19 2023-11-23 Vault Bioventures, Inc. Obesity treatment and prevention methods
WO2024141760A1 (en) 2022-12-30 2024-07-04 Algipharma As Compositions and methods to increase the systemic bioavailability of a polypeptide therapeutic agent undergoing oral administration
EP4568664A1 (en) 2023-04-07 2025-06-18 Terns Pharmaceuticals, Inc. Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating a liver disorder or a cardiometabolic disease
WO2025024455A1 (en) 2023-07-24 2025-01-30 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for delivery of therapeutic peptides
WO2025165146A1 (ko) * 2024-01-29 2025-08-07 주식회사 티온랩테라퓨틱스 세마글루타이드 또는 티르제파타이드의 개선된 의료 요법 제공을 위한 비만 및 당뇨 치료용으로써, 소수성 이온 페어링 겔레이션을 통한 초기 방출이 제어된 데포 조성물 및 이의 제조방법
CN118845644B (zh) * 2024-09-27 2025-01-17 杭州信海医药科技有限公司 一种司美格鲁肽注射液的制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010092163A2 (en) * 2009-02-13 2010-08-19 Boehringer Ingelheim International Gmbh Antidiabetic medications
RU2409349C2 (ru) * 2006-04-14 2011-01-20 Маннкайнд Корпорейшн Фармацевтические композиции, содержащие глюкагонподобный пептид(glp-1)
RU2413530C2 (ru) * 2004-11-12 2011-03-10 Ново Нордикс А/С Стабильные препараты инсулинотропных пептидов
WO2011138421A1 (en) * 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK39892D0 (da) 1992-03-25 1992-03-25 Bernard Thorens Peptid
ES2283025T3 (es) 1996-08-30 2007-10-16 Novo Nordisk A/S Derivados de glp-1.1.
JP5562510B2 (ja) 2001-06-28 2014-07-30 ノヴォ ノルディスク アー／エス 修飾ｇｌｐ−１の安定な処方剤
JP4949838B2 (ja) 2003-09-19 2012-06-13 ノヴォ ノルディスク アー／エス 新規ｇｌｐ−１誘導体
PL3300721T5 (pl) 2003-11-20 2025-11-17 Novo Nordisk A/S Preparaty peptydowe zawierające glikol propylenowy, które są optymalne do produkcji i do zastosowania w urządzeniu do wstrzykiwania
TWI372629B (en) 2005-03-18 2012-09-21 Novo Nordisk As Acylated glp-1 compounds
WO2008116088A1 (en) 2007-03-20 2008-09-25 Nippon Kayaku Kabushiki Kaisha Method to monitor drug efficacy in diabetic patients using an assay for 1,5-anhydro-d-glucitol
WO2008145728A1 (en) 2007-06-01 2008-12-04 Novo Nordisk A/S Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
JP5476304B2 (ja) 2007-09-05 2014-04-23 ノボ・ノルデイスク・エー／エス グルカゴン様ペプチド−１誘導体及びそれらの医薬用途
WO2009030774A1 (en) 2007-09-05 2009-03-12 Novo Nordisk A/S Truncated glp-1 derivatives and their therapeutical use
US20100317057A1 (en) 2007-12-28 2010-12-16 Novo Nordisk A/S Semi-recombinant preparation of glp-1 analogues
SI2373681T1 (sl) 2008-12-10 2017-05-31 Glaxosmithkline Llc Corporation Service Company Farmacevtski sestavki albiglutida
HUE027229T2 (en) * 2009-12-16 2016-08-29 Novo Nordisk As Double acylated glp-1 derivatives
WO2012016419A1 (zh) 2010-08-06 2012-02-09 浙江贝达药业有限公司 Glp-1衍生物及其应用
HRP20180425T1 (hr) 2010-12-16 2018-04-20 Novo Nordisk A/S Čvrste kompozicije koje sadrže agonist glp-1 i sol n-(8-(2-hidroksibenzoil)amino)kaprilne kiseline
US20130035281A1 (en) 2011-02-09 2013-02-07 Boehringer Ingelheim International Gmbh Pharmaceutical composition, methods for treating and uses thereof
CN102718858B (zh) 2011-03-29 2014-07-02 天津药物研究院 胰高血糖素样肽-1类似物单体、二聚体及其制备方法与应用
WO2012136790A1 (en) 2011-04-07 2012-10-11 Glaxo Group Limited Compositions comprising fusion proteins or conjugates with an improved half -life
CN102229668A (zh) 2011-06-03 2011-11-02 浙江贝达药业有限公司 一种glp-1衍生物及其应用
WO2012177929A2 (en) * 2011-06-24 2012-12-27 Amylin Pharmaceuticals, Inc. Methods for treating diabetes with extended release formulations of glp-1 receptor agonists
JP6059802B2 (ja) 2012-07-01 2017-01-11 ノヴォ ノルディスク アー／エス 長時間作用型ｇｌｐ−１ペプチドの使用

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2413530C2 (ru) * 2004-11-12 2011-03-10 Ново Нордикс А/С Стабильные препараты инсулинотропных пептидов
RU2409349C2 (ru) * 2006-04-14 2011-01-20 Маннкайнд Корпорейшн Фармацевтические композиции, содержащие глюкагонподобный пептид(glp-1)
WO2010092163A2 (en) * 2009-02-13 2010-08-19 Boehringer Ingelheim International Gmbh Antidiabetic medications
WO2011138421A1 (en) * 2010-05-05 2011-11-10 Boehringer Ingelheim International Gmbh Combination therapy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
S. MADSBAD et al. "An overview of once-weekly glucagons-like peptide -1 receptor agonists - available efficacy and safety data and perspectives for the future". Diabet, Obesity and detabolisv 13:394-407, 2011, с.401 левая колонка, 2 абзац, найдено 23.06.2017 из Интернет: http://onlinelibrary.wiley.com/doi/10.1111/j.1463-1326.2011.01357.x/abstract. *

Also Published As

Publication number Publication date
AU2020202573A1 (en) 2020-05-07
EP2866825A1 (en) 2015-05-06
MX2020010693A (es) 2020-11-06
RS60432B1 (sr) 2020-07-31
US9764003B2 (en) 2017-09-19
EP3689365B1 (en) 2025-08-06
RS67258B1 (sr) 2025-10-31
AU2020202573B2 (en) 2023-04-20
PT2866825T (pt) 2020-07-15
HUE049152T2 (hu) 2020-09-28
EP2866825B1 (en) 2020-04-08
EP4406593A3 (en) 2024-10-23
US20180085435A1 (en) 2018-03-29
ES3041720T3 (en) 2025-11-14
US20150190474A1 (en) 2015-07-09
JP2015522573A (ja) 2015-08-06
RU2015101826A (ru) 2016-08-20
RU2018117557A (ru) 2019-03-22
PL2866825T3 (pl) 2021-02-22
EP3689365A1 (en) 2020-08-05
HRP20251088T1 (hr) 2025-11-07
PL3689365T3 (pl) 2025-11-12
HRP20200889T1 (hr) 2020-09-04
AU2013286177A1 (en) 2015-01-15
EP4406593A2 (en) 2024-07-31
ES2796839T3 (es) 2020-11-30
WO2014005858A1 (en) 2014-01-09
AU2018202504B2 (en) 2020-05-07
MX2019008148A (es) 2019-09-05
BR112014032938A2 (pt) 2017-08-01
MX366405B (es) 2019-07-08
EP3689365C0 (en) 2025-08-06
AU2018202504A1 (en) 2018-05-10
MX376058B (es) 2025-03-07
RU2018117557A3 (enExample) 2021-08-20
US10335462B2 (en) 2019-07-02
SI2866825T1 (sl) 2020-07-31
JP6059802B2 (ja) 2017-01-11
DK2866825T3 (da) 2020-06-08
AU2013286177B2 (en) 2018-04-26
MX2014014946A (es) 2015-04-08
CA2877056A1 (en) 2014-01-09

Similar Documents

Publication Publication Date Title
RU2657573C2 (ru) Применение долгодействующих пептидов glp-1
RU2610175C2 (ru) Новые аналоги глюкагона
US11773150B2 (en) Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors
US20230063794A1 (en) Stapled triazole co-agonists of the glucagon and glp-1 receptors
EP4081244B1 (en) Stapled olefin co-agonists of the glucagon and glp-1 receptors
KR20250083391A (ko) Glp-1, gip, 및 아밀린 수용체의 삼중작용제